Fluocinonide and Pulmicort drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fluocinonide (fluocinonide) and Pulmicort (budesonide). Common drug interactions include abdominal wall abscess among females and colitis among males.

The phase IV clinical study analyzes what interactions people have when they take Fluocinonide and Pulmicort. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Fluocinonide?

Fluocinonide has active ingredients of fluocinonide. It is often used in eczema. eHealthMe is studying from 6,385 Fluocinonide users. Check the latest studies of Fluocinonide.

What is Pulmicort?

Pulmicort has active ingredients of budesonide. It is often used in asthma. eHealthMe is studying from 34,980 Pulmicort users. Check the latest studies of Pulmicort.

On Jul, 06, 2026

25 people who take Fluocinonide and Pulmicort together, and have interactions are studied.

Fluocinonide and Pulmicort drug interactions.

What are the common drug interactions of Fluocinonide and Pulmicort, by gender? *:

female:

Abdominal wall abscess (abdominal wall infection)
Device related infection
Drug ineffective
Ileal stenosis (obstruction in the ileal)
Oropharyngeal pain
Injection site reaction
Anxiety
Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
Wheezing (a high-pitched whistling sound made while you breath)
Abdominal pain

male:

Colitis (inflammation of colon)
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Angina pectoris (chest pain due to ischemia of the heart muscle)
Anxiety
Blindness
Blood pressure increased
Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
Disease progression
Dry skin
Dysphagia (a condition in which swallowing is difficult or painful)

What are the common drug interactions of Fluocinonide and Pulmicort, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
Device failure
Subcutaneous abscess

20-29:

n/a

30-39:

Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
Drug exposure during pregnancy
Lung disorder (lung disease)
Neuropathy peripheral (surface nerve damage)
Type 2 diabetes mellitus

40-49:

Colitis (inflammation of colon)
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Hepatic enzyme increased
Myeloid leukaemia (a type of cancer in which the bone marrow makes abnormal myeloblasts)
Nausea (feeling of having an urge to vomit)
Pelvic pain
Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
Rash follicular (redness of hair follicle)
Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
White blood cell count increased

50-59:

n/a

60+:

Abdominal wall abscess (abdominal wall infection)
Device related infection
Abdominal pain
Anaemia (lack of blood)
Angina pectoris (chest pain due to ischemia of the heart muscle)
Back pain
Blindness
Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
Colitis (inflammation of colon)
Colitis ulcerative (inflammation of colon with ulcer)

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 16.00%
Hypersensitivity: 3 people, 12.00%
Dry Eyes (lack of adequate tears): 3 people, 12.00%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 3 people, 12.00%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 3 people, 12.00%
Stress And Anxiety: 2 people, 8.00%
Pemphigus (any of several acute or chronic skin diseases characterized by groups of itching blisters): 2 people, 8.00%
Ocular Pemphigoid (inflammatory autoimmune disorder characterized by blistering lesions that affect mucous membrane covering of eye): 2 people, 8.00%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 8.00%
Depression: 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Fluocinonide and Pulmicort?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously